CMR Surgical announced today that its second-generation surgical robot, Versius Plus, received FDA 510(k) clearance.

The FDA previously granted marketing authorization for CMR’s first-generation Versius Surgical System through the De Novo ...

CMR Surgical secures 510(k) clearance of its Versius Plus robotic surgical system Regulatory clearance of CMR’s most advanced system paves the way for upcoming US commercial launch Strong clinical ...

The U.S. FDA recently cleared Medtronic plc’s Hugo robotic-assisted surgery system and CMR Surgical Ltd.’s Versius Plus ...

CMR Surgical has secured US Food and Drug Administration (FDA) clearance for its Versius Plus minimally invasive robotic surgical system, priming the company to go ahead with US commercialisation ...

“Built on years of global clinical use data, Versius Plus delivers the flexibility and intelligence today’s healthcare institutions need to advance robotic-assisted surgery,” said CEO Massimiliano ...

CMR Surgical, a British company developing the next-generation surgical robotic system and the Nicholson Center, a center of excellence for training, have launched the first U.S.-based training ...

CMR Surgical Ltd. secured more than $200 million in funding to bring its surgical robotic system, Versius, to the U.S. market and expand elsewhere. The financing, which came in the form of equity and ...